Tag: Parkinson’s
American Academy of Neurology, May 4-10
The 71st Annual Meeting of the American Academy of Neurology The annual meeting of the American Academy of Neurology was held from May...
DDW: Parkinson Disease Risk Up After Appendectomy
Risk greater for those aged 18 years and up, Caucasians, African-Americans, Asians
AAN: Isradipine Offers No Benefit in Parkinson Disease
No significant treatment effect seen in UPDRS Part I to III score measured in the ON state
Mindfulness Yoga Aids Patients With Parkinson Disease
Effects similar to those of stretching and resistance training for motor dysfunction, mobility
Questions Remain About Safety of Parkinson Disease Psychosis Drug
Federal government has received high number of reports about deaths among patients taking Nuplazid
Conversion From Sleep Disorder to Neurodegeneration Studied
Predictors include abnormal quantitative motor testing, MCI, olfactory deficit, motor symptoms
Levodopa + Carbidopa Does Not Modify Disease in Early Parkinson
Findings in patients with early Parkinson disease evaluated over the course of 80 weeks
Urate Elevation in Potential Tx for Parkinson’s Not Tied to HTN
Phase II clinical trial results, mouse model study show no link between serum urate, changes in BP
Gene Therapy Forms New Polysynaptic Pathways in Parkinson’s
Patients receiving GAD gene therapy develop unique treatment-dependent polysynaptic brain circuit
Reduced Survival for Patients With Idiopathic Parkinsonism
Mild cognitive impairment, freezing of gait, elevated leukocytes in CSF tied to shorter survival
